SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

HLS Therapeutics Announces Q3 2026 Financial Results

TORONTO, Nov. 12, 2026 /CNW/ -- HLS Therapeutics Inc. ("HLS" or the "Company") (TSX:HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease, announces its financial results for the three and nine months ended September 30…

HLS

Related stories